a developer of cell based immune therapeutics and vaccines for cancer treatment
Industry Biotechnology
A.I.dvisor tells us that MRKR and CGTX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MRKR and CGTX's prices will move in lockstep.
Ticker / NAME | Correlation To MRKR | 1D Price Change % | ||
---|---|---|---|---|
MRKR | 100% | -15.79% | ||
CGTX - MRKR | 30% Poorly correlated | -10.88% | ||
RPTX - MRKR | 23% Poorly correlated | -3.44% | ||
INTS - MRKR | 23% Poorly correlated | -1.84% | ||
UNCY - MRKR | 22% Poorly correlated | -5.89% | ||
MIRM - MRKR | 22% Poorly correlated | -4.18% | ||
More |
Ticker / NAME | Correlation To MRKR | 1D Price Change % |
---|---|---|
MRKR | 100% | -15.79% |
cancer theme (87 stocks) | 16% Poorly correlated | +0.89% |
immune theme (11 stocks) | 13% Poorly correlated | +1.62% |
vaccines theme (15 stocks) | 12% Poorly correlated | +1.51% |
personal theme (73 stocks) | 7% Poorly correlated | +0.66% |
consumer services theme (41 stocks) | 6% Poorly correlated | +0.48% |